Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3938448
Max Phase: Preclinical
Molecular Formula: C46H51ClN8O8S
Molecular Weight: 911.48
Molecule Type: Small molecule
Associated Items:
ID: ALA3938448
Max Phase: Preclinical
Molecular Formula: C46H51ClN8O8S
Molecular Weight: 911.48
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(=O)N1CCOC(CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cccc4[nH]cnc34)cc2[N+](=O)[O-])C1
Standard InChI: InChI=1S/C46H51ClN8O8S/c1-30(56)54-21-22-62-35(28-54)26-48-39-14-12-36(24-41(39)55(58)59)64(60,61)51-45(57)37-13-11-34(23-43(37)63-42-6-4-5-40-44(42)50-29-49-40)53-19-17-52(18-20-53)27-32-15-16-46(2,3)25-38(32)31-7-9-33(47)10-8-31/h4-14,23-24,29,35,48H,15-22,25-28H2,1-3H3,(H,49,50)(H,51,57)
Standard InChI Key: PEBYWYUAUQCZLW-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 911.48 | Molecular Weight (Monoisotopic): 910.3239 | AlogP: 7.48 | #Rotatable Bonds: 13 |
Polar Surface Area: 192.34 | Molecular Species: ACID | HBA: 12 | HBD: 3 |
#RO5 Violations: 3 | HBA (Lipinski): 16 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 4.18 | CX Basic pKa: 7.95 | CX LogP: 5.43 | CX LogD: 5.59 |
Aromatic Rings: 5 | Heavy Atoms: 64 | QED Weighted: 0.08 | Np Likeness Score: -1.13 |
1. (2015) Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases, |
Source(1):